<DOC>
	<DOCNO>NCT01018186</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety fluticasone furoate/GW642444</brief_summary>
	<brief_title>Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Clinical diagnosis asthma Reversibility FEV1 twelve percent great two hundred milliliter great approximately ten forty minute follow two four inhalation albuterol FEV1 great equal fifty percent predict Currently use moderate high dose inhale corticosteroid therapy History life threaten asthma Respiratory infection oral candidiasis Asthma exacerbation Uncontrolled disease clinical abnormality Allergies Taking another investigational medication prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>